K.J. Harrison & Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $481K | Hold |
5,800
| – | – | 0.08% | 155 |
|
|
2025
Q1 | $470K | Sell |
5,800
-18,000
| -76% | -$1.46M | 0.09% | 140 |
|
|
2024
Q4 | $2.18M | Buy |
23,800
+2,000
| +9% | +$183K | 0.34% | 77 |
|
|
2024
Q3 | $2.14M | Buy |
21,800
+800
| +4% | +$78.5K | 0.32% | 83 |
|
|
2024
Q2 | $1.95M | Buy |
21,000
+5,200
| +33% | +$482K | 0.32% | 81 |
|
|
2024
Q1 | $1.5M | Sell |
15,800
-5,012
| -24% | -$476K | 0.23% | 104 |
|
|
2023
Q4 | $1.86M | Buy |
+20,812
| New | +$1.86M | 0.32% | 87 |
|
|
2023
Q3 | – | Sell |
-5,800
| Closed | -$481K | – | 211 |
|
|
2023
Q2 | $481K | Hold |
5,800
| – | – | 0.09% | 164 |
|
|
2023
Q1 | $442K | Sell |
5,800
-11,000
| -65% | -$838K | 0.09% | 165 |
|
|
2022
Q4 | $1.89M | Buy |
+16,800
| New | +$1.89M | 0.37% | 88 |
|
|
2022
Q3 | – | Sell |
-33,200
| Closed | -$2.47M | – | 244 |
|
|
2022
Q2 | $2.47M | Buy |
33,200
+24,400
| +277% | +$1.81M | 0.67% | 45 |
|
|
2022
Q1 | $791K | Buy |
8,800
+900
| +11% | +$80.9K | 0.13% | 141 |
|
|
2021
Q4 | $886K | Buy |
+7,900
| New | +$886K | 0.13% | 170 |
|
|
2021
Q3 | – | Sell |
-4,000
| Closed | -$542 | – | 413 |
|
|
2021
Q2 | $542 | Sell |
4,000
-5,000
| -56% | -$678 | 0.06% | 201 |
|
|
2021
Q1 | $1.22M | Hold |
9,000
| – | – | 0.19% | 134 |
|
|
2020
Q4 | $1.27M | Sell |
9,000
-7,000
| -44% | -$985K | 0.21% | 139 |
|
|
2020
Q3 | $1.79M | Sell |
16,000
-11,000
| -41% | -$1.23M | 0.37% | 91 |
|
|
2020
Q2 | $3.02M | Buy |
+27,000
| New | +$3.02M | 0.83% | 40 |
|